Literature DB >> 25287704

A β1-6/β1-3 galactosidase from Bifidobacterium animalis subsp. lactis Bl-04 gives insight into sub-specificities of β-galactoside catabolism within Bifidobacterium.

Alexander Holm Viborg1, Folmer Fredslund, Takane Katayama, Stinne Kirketerp Nielsen, Birte Svensson, Motomitsu Kitaoka, Leila Lo Leggio, Maher Abou Hachem.   

Abstract

The Bifidobacterium genus harbours several health promoting members of the gut microbiota. Bifidobacteria display metabolic specialization by preferentially utilizing dietary or host-derived β-galactosides. This study investigates the biochemistry and structure of a glycoside hydrolase family 42 (GH42) β-galactosidase from the probiotic Bifidobacterium animalis subsp. lactis Bl-04 (BlGal42A). BlGal42A displays a preference for undecorated β1-6 and β1-3 linked galactosides and populates a phylogenetic cluster with close bifidobacterial homologues implicated in the utilization of N-acetyl substituted β1-3 galactosides from human milk and mucin. A long loop containing an invariant tryptophan in GH42, proposed to bind substrate at subsite + 1, is identified here as specificity signature within this clade of bifidobacterial enzymes. Galactose binding at the subsite - 1 of the active site induced conformational changes resulting in an extra polar interaction and the ordering of a flexible loop that narrows the active site. The amino acid sequence of this loop provides an additional specificity signature within this GH42 clade. The phylogenetic relatedness of enzymes targeting β1-6 and β1-3 galactosides likely reflects structural differences between these substrates and β1-4 galactosides, containing an axial galactosidic bond. These data advance our molecular understanding of the evolution of sub-specificities that support metabolic specialization in the gut niche.
© 2014 John Wiley & Sons Ltd.

Entities:  

Year:  2014        PMID: 25287704     DOI: 10.1111/mmi.12815

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  7 in total

1.  Substrate preference of an ABC importer corresponds to selective growth on β-(1,6)-galactosides in Bifidobacterium animalis subsp. lactis.

Authors:  Mia Christine Theilmann; Folmer Fredslund; Birte Svensson; Leila Lo Leggio; Maher Abou Hachem
Journal:  J Biol Chem       Date:  2019-06-11       Impact factor: 5.157

2.  The Structure of an Archaeal β-Glucosaminidase Provides Insight into Glycoside Hydrolase Evolution.

Authors:  Shouhei Mine; Masahiro Watanabe; Saori Kamachi; Yoshito Abe; Tadashi Ueda
Journal:  J Biol Chem       Date:  2017-01-27       Impact factor: 5.157

3.  Discovery of α-l-arabinopyranosidases from human gut microbiome expands the diversity within glycoside hydrolase family 42.

Authors:  Alexander Holm Viborg; Takane Katayama; Takatoshi Arakawa; Maher Abou Hachem; Leila Lo Leggio; Motomitsu Kitaoka; Birte Svensson; Shinya Fushinobu
Journal:  J Biol Chem       Date:  2017-10-23       Impact factor: 5.157

Review 4.  Structure and evolution of the bifidobacterial carbohydrate metabolism proteins and enzymes.

Authors:  Shinya Fushinobu; Maher Abou Hachem
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

5.  Biochemical analysis of cross-feeding behaviour between two common gut commensals when cultivated on plant-derived arabinogalactan.

Authors:  Jose Munoz; Kieran James; Francesca Bottacini; Douwe Van Sinderen
Journal:  Microb Biotechnol       Date:  2020-05-09       Impact factor: 5.813

Review 6.  Cold-Active β-Galactosidases: Insight into Cold Adaption Mechanisms and Biotechnological Exploitation.

Authors:  Marco Mangiagalli; Marina Lotti
Journal:  Mar Drugs       Date:  2021-01-19       Impact factor: 5.118

7.  Cloning, Expression, Purification, and Characterization of β-Galactosidase from Bifidobacterium longum and Bifidobacterium pseudocatenulatum.

Authors:  Mingzhu Du; Shuanghong Yang; Tong Jiang; Tingting Liang; Ying Li; Shuzhen Cai; Qingping Wu; Jumei Zhang; Wei Chen; Xinqiang Xie
Journal:  Molecules       Date:  2022-07-14       Impact factor: 4.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.